Network Meta-Analysis of Once Weekly Selinexor-Bortezomib-Dexamethasone in Previously Treated Multiple Myeloma

Background: Despite the availability of new treatments, multiple myeloma (MM) is an incurable cancer with nearly all patients relapsing and undergoing multiple lines of treatment. Performing head-to-head comparisons of all treatment options is not feasible. Thus, network meta-analyses play an import...

Descripción completa

Detalles Bibliográficos
Autores principales: Dolph, Michael, Tremblay, Gabriel, Gilligan, Adrienne M, Leong, Hoyee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Columbia Data Analytics, LLC 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8460427/
https://www.ncbi.nlm.nih.gov/pubmed/34616855
http://dx.doi.org/10.36469/001c.27080

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8460427/
https://www.ncbi.nlm.nih.gov/pubmed/34616855
http://dx.doi.org/10.36469/001c.27080

Ejemplares similares